Influenza Virus Sialidase - A Drug Discovery Target

Nonfiction, Health & Well Being, Medical, Ailments & Diseases, Infectious Diseases, General, Medical Science, Pharmacology
Cover of the book Influenza Virus Sialidase - A Drug Discovery Target by , Springer Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783764389277
Publisher: Springer Basel Publication: September 1, 2011
Imprint: Springer Language: English
Author:
ISBN: 9783764389277
Publisher: Springer Basel
Publication: September 1, 2011
Imprint: Springer
Language: English

Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge.

This volume describes all aspects of the virus structure and function relevant to infection. The focus is on drug discovery of inhibitors to the enzyme sialidase, which plays a key role in the infectious lifecycle of the virus. Following an overview of the influenza virus, thehaemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented. These include a full coverage of the design, synthesis and evaluation of carbohydrate as well as non-carbohydrate influenza virus sialidase inhibitors. Further reviews of the clinical experience with influenza virus sialidase inhibitors and of the development of resistance to these inhibitor drugs complement the topic.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge.

This volume describes all aspects of the virus structure and function relevant to infection. The focus is on drug discovery of inhibitors to the enzyme sialidase, which plays a key role in the infectious lifecycle of the virus. Following an overview of the influenza virus, thehaemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented. These include a full coverage of the design, synthesis and evaluation of carbohydrate as well as non-carbohydrate influenza virus sialidase inhibitors. Further reviews of the clinical experience with influenza virus sialidase inhibitors and of the development of resistance to these inhibitor drugs complement the topic.

More books from Springer Basel

Cover of the book And Yet It Is Heard by
Cover of the book Ibuprofen: Pharmacology, Therapeutics and Side Effects by
Cover of the book The Power of the Terroir: the Case Study of Prosecco Wine by
Cover of the book Drugs for HER-2-positive Breast Cancer by
Cover of the book Influenza Vaccines for the Future by
Cover of the book Microlocal Methods in Mathematical Physics and Global Analysis by
Cover of the book Berichte zu Pflanzenschutzmitteln 2011 by
Cover of the book Proteases and Their Receptors in Inflammation by
Cover of the book Galanin by
Cover of the book Inflammation and Cancer by
Cover of the book Control and Optimization with PDE Constraints by
Cover of the book Berichte zur Resistenzmonitoringstudie 2008 by
Cover of the book Drugs Targeting B-Cells in Autoimmune Diseases by
Cover of the book Human Medical Research by
Cover of the book Tamoxifen by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy